Evidence map›Paper›PMID 42192854›Full record

ReviewBrain sciences2026

Modulation of the PI3K/AKT/mTOR and AMPK/TSC2/mTOR Pathways by N-Acetyl-L-Cysteine as a Protector of Embryonic Bodies from the Toxic Effect of Methylmercury.

Júlia Leão Batista Simões, Geórgia de Carvalho Braga, Charles Elias Assmann, Margarete Dulce Bagatini

Abstract readReview
In one paragraph

Review in Brain sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Júlia Leão Batista SimõesGraduate Program in Biochemistry, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.ORCID 0000-0002-1652-9692
Geórgia de Carvalho BragaMedical School, Federal University of Fronteira Sul, Chapecó 89815-899, SC, Brazil.ORCID 0000-0003-0384-9934
Charles Elias AssmannGraduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria, Santa Maria 97105-900, RS, Brazil.ORCID 0000-0002-3524-3446
Margarete Dulce BagatiniGraduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó 89815-899, SC, Brazil.ORCID 0000-0001-9263-4980

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Not applicableFundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina Grant 2: No. 2024TR002502Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina Grant 3: No. 2025TR001686Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina M.D.B.; Grant 1: No. 2023TR001472National Council for Scientific and Technological Development Grant 1: Instituto Nacional Sinalização Purinérgica: Desafios para a Saúde do Século 21; No. 409156/2024-8National Council for Scientific and Technological Development Grant 2: M.D.B.; No. 305974/2025-4Universidade Federal da Fronteira Sul Not applicable
6 · The paper itself

Abstract

Methylmercury (MeHg) is a potent environmental contaminant primarily ingested through seafood consumption. Gestational exposure induces profound neurological and developmental deficits in the fetus that often persist throughout childhood. This developmental vulnerability arises from the immature state of the blood-brain barrier and a limited endogenous antioxidant capacity in the developing CNS. Postnatal exposure via breastfeeding further compromises neurodevelopment, specifically impairing visuospatial processing and memory. While fetal and placental mercury accumulation correlates with gestational age, the specific mechanisms of transplacental transport remain poorly defined. Mechanistically, MeHg predominantly accumulates in fetal renal tissue, followed by the brain and liver. This review aims to elucidate MeHg-induced oxidative stress and autophagic collapse mediated by the PI3K/AKT/mTOR and AMPK/TSC2/mTOR pathways. Furthermore, we evaluate neuroprotective candidates, specifically N-acetyl-L-cysteine (NAC) and CCL chemokine modulation, as strategies to mitigate fetal impairment and the associated cellular damage.

Indexed as

autophagydevelopmental impairmentmethylmercurymTORN-acetyl-L-cysteineoxidative stress

Identifiers

PMID42192854
PMCPMC13204640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.